Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Source:http://linkedlifedata.com/resource/pubmed/id/11250810

Download in:

View as

General Info

PMID
11250810